Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 28, Issue 7, Pages 1519-1528
Publisher
Springer Nature
Online
2014-01-09
DOI
10.1038/leu.2014.2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro
- (2013) Maike Sauer et al. BIOLOGICAL CHEMISTRY
- NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
- (2013) Yihui Fan et al. Protein & Cell
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy
- (2012) Ashley J. Knights et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- Transfer of extracellular vesicles during immune cell-cell interactions
- (2012) Cristina Gutiérrez-Vázquez et al. IMMUNOLOGICAL REVIEWS
- Bone Marrow Microenvironment in Multiple Myeloma Progression
- (2012) S. Manier et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway
- (2012) Vijay Ramakrishnan et al. PLoS One
- Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation
- (2012) Chang Yang et al. Cancer Discovery
- Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
- (2011) M Darding et al. CELL DEATH AND DIFFERENTIATION
- MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
- (2011) V Ramakrishnan et al. LEUKEMIA
- Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment
- (2011) J. Lu et al. MOLECULAR CANCER THERAPEUTICS
- Ripoptosome: a novel IAP-regulated cell death-signalling platform
- (2011) G. Imre et al. Journal of Molecular Cell Biology
- TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
- (2010) Vijay Ramakrishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Classical and/or alternative NF- B pathway activation in multiple myeloma
- (2010) Y. N. Demchenko et al. BLOOD
- The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
- (2010) A Scuto et al. LEUKEMIA
- Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression
- (2010) S. L. Petersen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Life and death by death receptors
- (2009) Maria Eugenia Guicciardi et al. FASEB JOURNAL
- Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
- (2009) Peter Geserick et al. JOURNAL OF CELL BIOLOGY
- Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
- (2009) V Ramakrishnan et al. ONCOGENE
- Bcl-2-family proteins and hematologic malignancies: history and future prospects
- (2008) J. C. Reed BLOOD
- Impact of XIAP protein levels on the survival of myeloma cells
- (2008) G. Desplanques et al. HAEMATOLOGICA
- c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation
- (2008) Eugene Varfolomeev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
- Bcl-2 family proteins and cancer
- (2008) K W Yip et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started